Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
65,767,971
-
Total 13F shares
-
34,724,554
-
Share change
-
+34,039,594
-
Total reported value
-
$342,890,571
-
Price per share
-
$9.90
-
Number of holders
-
51
-
Value change
-
+$336,109,467
-
Number of buys
-
49
Institutional Holders of Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) as of Q4 2025
As of 31 Dec 2025,
Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,724,554 shares.
The largest 10 holders included
Magnetar Financial LLC, Glazer Capital, LLC, First Trust Capital Management L.P., Hudson Bay Capital Management LP, Polar Asset Management Partners Inc., TENOR CAPITAL MANAGEMENT Co., L.P., MILLENNIUM MANAGEMENT LLC, HGC Investment Management Inc., AQR Arbitrage LLC, and Karpus Management, Inc..
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.